SPIMACO

Saudi Pharmaceutical Industries & Medical Appliances Corp.

2070StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operating Summary
Revenue	1.71B	1.68B	1.66B	1.42B	1.46B
Cost of Revenue	886.06M	865.95M	965.80M	864.50M	846.73M
Gross Profit	820.65M	816.05M	689.64M	557.31M	613.05M
SG&A	521.41M	591.03M	615.47M	620.63M	551.26M
R&D	60.48M	76.39M	41.80M	42.65M	29.07M
Operating Expenses	594.05M	700.03M	629.92M	665.39M	580.22M
Operating Income	226.60M	116.02M	59.72M	-108.08M	32.83M
Interest Income	13.20M	7.66M	10.59M	—	—
Interest Expense	-89.03M	-86.77M	-63.51M	-34.33M	-31.40M
Other Income/Expense	—	—	-3.17M	—	-1.49M
Pretax Income	205.65M	72.01M	5.21M	-132.59M	33.73M
Income Tax	8.84M	40.17M	45.26M	25.90M	12.35M
Net Income	184.36M	24.54M	-50.73M	-165.14M	26.45M
EBITDA	305.40M	190.99M	131.34M	-28.21M	112.57M
EBIT	226.60M	116.02M	59.72M	-108.08M	32.83M
EPS (Basic)	1.54	0.21	-0.42	-1.38	0.22
EPS (Diluted)	1.54	0.21	-0.42	-1.38	0.22
DPS	0.35	—	—	—	0.60
Margins & Efficiency
Gross Margin %	+48.1%	+48.5%	+41.7%	+39.2%	+42.0%
EBITDA Margin %	+17.9%	+11.4%	+7.9%	-2.0%	+7.7%
Net Margin %	+10.8%	+1.5%	-3.1%	-11.6%	+1.8%
Revenue & Income
Revenue	1.71B	1.68B	1.66B	1.42B	1.46B
Revenue Growth (YoY)	+1.5%	+1.6%	+16.4%	-2.6%	-6.1%
Interest & Investment Income	13.20M	7.66M	10.59M	—	—
Earnings From Equity Investments	24.35M	22.73M	20.00M	20.44M	11.41M
Gain (Loss) on Sale of Assets	28.70M	18.94M	6.38M	0.14M	-0.45M
Gain (Loss) on Sale of Investments	—	—	—	3.63M	7.81M
Currency Exchange Gain (Loss)	3.46M	-10.16M	-4.32M	-14.38M	15.03M
Expenses & Provisions
Advertising Expenses	39.67M	33.20M	56.75M	41.89M	40.43M
Cost of Revenue	886.06M	865.95M	965.80M	864.50M	846.73M
Selling, General & Admin	521.41M	591.03M	615.47M	620.63M	551.26M
Research & Development	60.48M	76.39M	41.80M	42.65M	29.07M
Operating Expenses	594.05M	700.03M	629.92M	665.39M	580.22M
Other Operating Expenses	-9.14M	-4.44M	-69.39M	-7.93M	13.74M
Interest Expense	-89.03M	-86.77M	-63.51M	-34.33M	-31.40M
Other Non Operating Income (Expenses)	—	—	-3.17M	—	-1.49M
Legal Settlements	-1.64M	5.05M	-20.47M	—	—
Asset Writedown	—	-1.46M	—	—	—
D&A For EBITDA	78.80M	74.96M	71.62M	79.87M	79.74M
Profitability & Returns
Gross Profit	820.65M	816.05M	689.64M	557.31M	613.05M
Gross Margin	+48.1%	+48.5%	+41.7%	+39.2%	+42.0%
EBIT	226.60M	116.02M	59.72M	-108.08M	32.83M
EBIT Margin	+13.3%	+6.9%	+3.6%	-7.6%	+2.2%
EBITDA	305.40M	190.99M	131.34M	-28.21M	112.57M
EBITDA Margin	+17.9%	+11.4%	+7.9%	-2.0%	+7.7%
EBT Excluding Unusual Items	178.59M	49.48M	19.30M	-136.35M	26.38M
Pretax Income	205.65M	72.01M	5.21M	-132.59M	33.73M
Operating Income	226.60M	116.02M	59.72M	-108.08M	32.83M
Operating Margin	+13.3%	+6.9%	+3.6%	-7.6%	+2.2%
Profit Margin	+10.8%	+1.5%	-3.1%	-11.6%	+1.8%
Net Income	184.36M	24.54M	-50.73M	-165.14M	26.45M
Net Income to Common	184.36M	24.54M	-50.73M	-165.14M	26.45M
Net Income to Company	196.81M	31.84M	-40.05M	-171.23M	18.10M
Net Income Growth	+651.4%	—	—	—	-78.8%
Earnings From Continuing Ops.	196.81M	31.84M	-40.05M	-158.48M	21.38M
Earnings From Discontinued Ops.	—	—	—	-12.75M	-3.28M
Minority Interest in Earnings	-12.45M	-7.31M	-10.68M	6.10M	8.35M
Income Tax Expense	8.84M	40.17M	45.26M	25.90M	12.35M
Effective Tax Rate	+4.3%	+55.8%	+868.2%	—	+36.6%
Per Share & Capital
EPS (Basic)	1.54	0.21	-0.42	-1.38	0.22
EPS (Diluted)	1.54	0.21	-0.42	-1.38	0.22
EPS Growth	+652.5%	—	—	—	-78.8%
Dividend Per Share	0.35	—	—	—	0.60
Shares Change (YoY)	-0	-0	-0	—	—
Shares Outstanding (Basic)	119.36M	119.53M	119.63M	120.00M	120.00M
Shares Outstanding (Diluted)	119.36M	119.53M	119.63M	120.00M	120.00M
Dividend Growth	—	—	—	—	-40.0%
Free Cash Flow	183.21M	-402.23M	-95.92M	-177.51M	10.47M
Free Cash Flow Margin	+10.7%	-23.9%	-5.8%	-12.5%	+0.7%
Free Cash Flow Per Share	1.54	-3.37	-0.80	-1.48	0.09
Payout Ratio	—	+11.3%	—	—	+446.5%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operating Summary
Revenue	1.71B	1.68B	1.66B	1.42B	1.46B
Cost of Revenue	886.06M	865.95M	965.80M	864.50M	846.73M
Gross Profit	820.65M	816.05M	689.64M	557.31M	613.05M
SG&A	521.41M	591.03M	615.47M	620.63M	551.26M
R&D	60.48M	76.39M	41.80M	42.65M	29.07M
Operating Expenses	594.05M	700.03M	629.92M	665.39M	580.22M
Operating Income	226.60M	116.02M	59.72M	-108.08M	32.83M
Interest Income	13.20M	7.66M	10.59M	—	—
Interest Expense	-89.03M	-86.77M	-63.51M	-34.33M	-31.40M
Other Income/Expense	—	—	-3.17M	—	-1.49M
Pretax Income	205.65M	72.01M	5.21M	-132.59M	33.73M
Income Tax	8.84M	40.17M	45.26M	25.90M	12.35M
Net Income	184.36M	24.54M	-50.73M	-165.14M	26.45M
EBITDA	305.40M	190.99M	131.34M	-28.21M	112.57M
EBIT	226.60M	116.02M	59.72M	-108.08M	32.83M
EPS (Basic)	1.54	0.21	-0.42	-1.38	0.22
EPS (Diluted)	1.54	0.21	-0.42	-1.38	0.22
DPS	0.35	—	—	—	0.60
Margins & Efficiency
Gross Margin %	+48.1%	+48.5%	+41.7%	+39.2%	+42.0%
EBITDA Margin %	+17.9%	+11.4%	+7.9%	-2.0%	+7.7%
Net Margin %	+10.8%	+1.5%	-3.1%	-11.6%	+1.8%
Revenue & Income
Revenue	1.71B	1.68B	1.66B	1.42B	1.46B
Revenue Growth (YoY)	+1.5%	+1.6%	+16.4%	-2.6%	-6.1%
Interest & Investment Income	13.20M	7.66M	10.59M	—	—
Earnings From Equity Investments	24.35M	22.73M	20.00M	20.44M	11.41M
Gain (Loss) on Sale of Assets	28.70M	18.94M	6.38M	0.14M	-0.45M
Gain (Loss) on Sale of Investments	—	—	—	3.63M	7.81M
Currency Exchange Gain (Loss)	3.46M	-10.16M	-4.32M	-14.38M	15.03M
Expenses & Provisions
Advertising Expenses	39.67M	33.20M	56.75M	41.89M	40.43M
Cost of Revenue	886.06M	865.95M	965.80M	864.50M	846.73M
Selling, General & Admin	521.41M	591.03M	615.47M	620.63M	551.26M
Research & Development	60.48M	76.39M	41.80M	42.65M	29.07M
Operating Expenses	594.05M	700.03M	629.92M	665.39M	580.22M
Other Operating Expenses	-9.14M	-4.44M	-69.39M	-7.93M	13.74M
Interest Expense	-89.03M	-86.77M	-63.51M	-34.33M	-31.40M
Other Non Operating Income (Expenses)	—	—	-3.17M	—	-1.49M
Legal Settlements	-1.64M	5.05M	-20.47M	—	—
Asset Writedown	—	-1.46M	—	—	—
D&A For EBITDA	78.80M	74.96M	71.62M	79.87M	79.74M
Profitability & Returns
Gross Profit	820.65M	816.05M	689.64M	557.31M	613.05M
Gross Margin	+48.1%	+48.5%	+41.7%	+39.2%	+42.0%
EBIT	226.60M	116.02M	59.72M	-108.08M	32.83M
EBIT Margin	+13.3%	+6.9%	+3.6%	-7.6%	+2.2%
EBITDA	305.40M	190.99M	131.34M	-28.21M	112.57M
EBITDA Margin	+17.9%	+11.4%	+7.9%	-2.0%	+7.7%
EBT Excluding Unusual Items	178.59M	49.48M	19.30M	-136.35M	26.38M
Pretax Income	205.65M	72.01M	5.21M	-132.59M	33.73M
Operating Income	226.60M	116.02M	59.72M	-108.08M	32.83M
Operating Margin	+13.3%	+6.9%	+3.6%	-7.6%	+2.2%
Profit Margin	+10.8%	+1.5%	-3.1%	-11.6%	+1.8%
Net Income	184.36M	24.54M	-50.73M	-165.14M	26.45M
Net Income to Common	184.36M	24.54M	-50.73M	-165.14M	26.45M
Net Income to Company	196.81M	31.84M	-40.05M	-171.23M	18.10M
Net Income Growth	+651.4%	—	—	—	-78.8%
Earnings From Continuing Ops.	196.81M	31.84M	-40.05M	-158.48M	21.38M
Earnings From Discontinued Ops.	—	—	—	-12.75M	-3.28M
Minority Interest in Earnings	-12.45M	-7.31M	-10.68M	6.10M	8.35M
Income Tax Expense	8.84M	40.17M	45.26M	25.90M	12.35M
Effective Tax Rate	+4.3%	+55.8%	+868.2%	—	+36.6%
Per Share & Capital
EPS (Basic)	1.54	0.21	-0.42	-1.38	0.22
EPS (Diluted)	1.54	0.21	-0.42	-1.38	0.22
EPS Growth	+652.5%	—	—	—	-78.8%
Dividend Per Share	0.35	—	—	—	0.60
Shares Change (YoY)	-0	-0	-0	—	—
Shares Outstanding (Basic)	119.36M	119.53M	119.63M	120.00M	120.00M
Shares Outstanding (Diluted)	119.36M	119.53M	119.63M	120.00M	120.00M
Dividend Growth	—	—	—	—	-40.0%
Free Cash Flow	183.21M	-402.23M	-95.92M	-177.51M	10.47M
Free Cash Flow Margin	+10.7%	-23.9%	-5.8%	-12.5%	+0.7%
Free Cash Flow Per Share	1.54	-3.37	-0.80	-1.48	0.09
Payout Ratio	—	+11.3%	—	—	+446.5%